Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Trajectories of depressive symptoms following breast cancer diagnosis.

Avis NE, Levine BJ, Case LD, Naftalis EZ, Van Zee KJ.

Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1789-95. doi: 10.1158/1055-9965.EPI-15-0327. Epub 2015 Sep 16.

2.

Trajectories of Posttraumatic Growth and Associated Characteristics in Women with Breast Cancer.

Danhauer SC, Russell G, Case LD, Sohl SJ, Tedeschi RG, Addington EL, Triplett K, Van Zee KJ, Naftalis EZ, Levine B, Avis NE.

Ann Behav Med. 2015 Oct;49(5):650-9. doi: 10.1007/s12160-015-9696-1.

3.

Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study.

Petrek JA, Naughton MJ, Case LD, Paskett ED, Naftalis EZ, Singletary SE, Sukumvanich P.

J Clin Oncol. 2006 Mar 1;24(7):1045-51. Epub 2006 Feb 13.

PMID:
16476708
4.

Custodianship of genetic information: clinical challenges and professional responsibility.

Patterson AR, Robinson LD, Naftalis EZ, Haley BB, Tomlinson GE.

J Clin Oncol. 2005 Mar 20;23(9):2100-4. No abstract available.

PMID:
15774800
5.

Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk.

Lewis CM, Cler LR, Bu DW, Zöchbauer-Müller S, Milchgrub S, Naftalis EZ, Leitch AM, Minna JD, Euhus DM.

Clin Cancer Res. 2005 Jan 1;11(1):166-72.

6.

Circulating tumor cells in patients with breast cancer dormancy.

Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, Beitsch PD, Leitch M, Hoover S, Euhus D, Haley B, Morrison L, Fleming TP, Herlyn D, Terstappen LW, Fehm T, Tucker TF, Lane N, Wang J, Uhr JW.

Clin Cancer Res. 2004 Dec 15;10(24):8152-62.

Supplemental Content

Loading ...
Support Center